Stay updated on Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, particularly the removal of detailed descriptions of the HZNP-HZN-825-303 clinical trial phases and inclusion/exclusion criteria for participants, while retaining the mention of Idiopathic Pulmonary Fibrosis and the EudraCT number.SummaryDifference35%
- Check29 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding two new dates: February 4, 2025, and March 6, 2025.SummaryDifference0.2%
- Check37 days agoChange DetectedThe page has updated its certification and extension dates, reflecting a new first posted date of March 25, 2025, and a last update date that has been revised to reflect the latest version 2.14.3.SummaryDifference0.2%
- Check59 days agoChange DetectedThe page has updated its certification and extension dates, with the addition of new dates for 2025 and the removal of older dates from January and February 2025.SummaryDifference0.5%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
Stay in the know with updates to Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial page.